---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-030803"
form_type: "8-K"
ticker: "SOLV"
cik: "0001964738"
company_name: "Solventum Corp"
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T14:01:13.202513+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Solventum amends purification & filtration sale to Thermo Fisher; consideration reduced to ~$4.0B

## Summary
- Amended agreement on June 25, 2025 excludes drinking water filtration business; cash consideration cut from $4.1B to ~$4.0B.
- Pro forma net income for H1 2025: $86M (vs historical $227M) after removal of business and transaction adjustments.
- Pro forma net income for FY2024: $1,677M (vs historical $479M) including $1.56B estimated pre-tax gain on sale.
- Net cash proceeds estimated at $3.89B after costs, working capital, and debt adjustments; proceeds to be used for debt paydown.
- Transaction expected to close with customary adjustments; ~$98M non-current assets remain due to delayed transfers in certain jurisdictions.

## SEC filing metadata
- accession: 0001140361-25-030803
- form_type: 8-K
- ticker: SOLV
- cik: 0001964738
- company_name: Solventum Corp
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964738/000114036125030803/0001140361-25-030803-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964738/000114036125030803/ef20053560_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-030803
- JSON: https://secwatch.observer/filing/0001140361-25-030803.json
- Plain text: https://secwatch.observer/filing/0001140361-25-030803.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.